Senti Bio Receives $8 Million CIRM Grant to Advance Logic-Gated CAR-NK Cell Therapy for AML Read More »
BrainStorm Cell Therapeutics Aligns with FDA on Phase 3b NurOwn Clinical Trial CMC Aspects Read More »
iRegene Receives IND Approval from U.S. FDA to Start Clinical Trial for Parkinson’s Disease Read More »
